Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes

被引:143
作者
Xu, R
Janson, CG
Mastakov, M
Lawlor, P
Young, D
Mouravlev, A
Fitzsimons, H
Choi, KL
Ma, H
Dragunow, M
Leone, P
Chen, Q
Dicker, B
During, MJ
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, CNS Gene Therapy Ctr, Philadelphia, PA 19107 USA
[2] Univ Auckland, Sch Med, Dept Mol Med, Auckland, New Zealand
[3] Yale Univ, Sch Med, Mol Pharmacol & Neurogenet Lab, New Haven, CT USA
关键词
gene cassette; adeno-associated virus; neuron; promoter; post-regulatory element; functional genomics;
D O I
10.1038/sj.gt.3301529
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study compared a range of mammalian CNS expression cassettes in recombinant adeno-associated virus (AAV-2) vectors using strong endogenous promoter sequences, with or without a strong post-regulatory element and polyadenylation signal. Changes in these elements led to transgene expression varying by over three orders of magnitude. In experiments conducted in primary cell culture and in > 100 stereotactically injected rats, we observed highly efficient and stable (> 15 months) gene expression in neurons and limited expression in glia; the highest expression occurred with endogenous, nonviral promoters such as neuron-specific enolase and beta -actin. The packaging size of AAV-2 was maximized at 5.7 kb without impairing gene expression, as judged by direct comparison with a number of smaller AAV-2 constructs. The genomic insert size and titer were confirmed by Southern blot and quantitative PCR, and infectivity was tested by particle titer using ELISA with a conformation-dependent epitope that requires the full intact capsid. A packaging and purification protocol we describe allows for high-titer, high-capacity AAV-2 vectors that can transduce over 2 x 10(5) neurons in vivo per microliter of vector, using the strongest expression cassette.
引用
收藏
页码:1323 / 1332
页数:10
相关论文
共 58 条
  • [1] GENE-TRANSFER INTO MAMMALIAN CENTRAL-NERVOUS-SYSTEM USING HERPES-VIRUS VECTORS - EXTENDED EXPRESSION OF BACTERIAL LACZ IN NEURONS USING THE NEURON-SPECIFIC ENOLASE PROMOTER
    ANDERSEN, JK
    GARBER, DA
    MEANEY, CA
    BREAKEFIELD, XO
    [J]. HUMAN GENE THERAPY, 1992, 3 (05) : 487 - 499
  • [2] HERPESVIRUS-MEDIATED GENE DELIVERY INTO THE RAT-BRAIN - SPECIFICITY AND EFFICIENCY OF THE NEURON-SPECIFIC ENOLASE PROMOTER
    ANDERSEN, JK
    FRIM, DM
    ISACSON, O
    BREAKEFIELD, XO
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 1993, 13 (05) : 503 - 515
  • [3] Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes
    Bansal, R
    Kumar, M
    Murray, K
    Pfeiffer, SE
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 1996, 7 (04) : 276 - 288
  • [4] Selective and rapid uptake of adeno-associated virus type 2 in brain
    Bartlett, JS
    Samulski, RJ
    McCown, TJ
    [J]. HUMAN GENE THERAPY, 1998, 9 (08) : 1181 - 1186
  • [5] Blomer U, 1997, J VIROL, V71, P6641
  • [6] Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS
    Chamberlin, NL
    Du, B
    de Lacalle, S
    Saper, CB
    [J]. BRAIN RESEARCH, 1998, 793 (1-2) : 169 - 175
  • [7] Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus
    Chen, H
    McCarty, DM
    Bruce, AT
    Suzuki, K
    Suzuki, K
    [J]. GENE THERAPY, 1998, 5 (01) : 50 - 58
  • [8] Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses
    Clark, KR
    Liu, XL
    McGrath, JP
    Johnson, PR
    [J]. HUMAN GENE THERAPY, 1999, 10 (06) : 1031 - 1039
  • [9] Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system
    Davidson, BL
    Stein, CS
    Heth, JA
    Martins, I
    Kotin, RM
    Derksen, TA
    Zabner, J
    Ghodsi, A
    Chiorini, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3428 - 3432
  • [10] Doll RF, 1996, GENE THER, V3, P437